← Insider buys
KPTI

Karyopharm Therapeutics Inc. · Healthcare

EVP and Chief Medical Officer Jatin Shah sold $27K of Karyopharm Therapeutics Inc.

Sold$27,127
$15.52Price
1,748Shares
−3%Stake

What KPTI did after the filing

Prices for KPTI after this filing aren't in yet.

Traded Thu, Feb 11. Filed Wed, Feb 17, 1:48 PM ET, during the session. Not investment advice.